Literature DB >> 6733281

Abnormal processing of beta Knossos RNA.

S H Orkin, S E Antonarakis, D Loukopoulos.   

Abstract

Hemoglobin beta Knossos (beta 27Ala-Ser) is a cause of beta-thalassemia due to its reduced synthesis. To investigate the basis for this observation, we have isolated the beta Knossos gene and examined its expression in heterologous cells. We have found that some beta Knossos RNA transcripts are abnormally processed, utilizing a cryptic splice sequence that is enhanced by the Knossos substitution. This form of abnormal RNA processing is seen in two other mutations in this region (a silent substitution in codon 24 and the substitution in codon 26 that produces the beta E variant) and most likely contributes appreciably to the reduced synthesis of beta Knossos.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733281

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

Review 2.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

3.  Hb Knossos: HBB:c.82G>T Associated with HBB:c.315+1G>A Beta Zero Mutation Causes Thalassemia Intermedia.

Authors:  Hengameh Nasouhipur; Ali Banihashemi; Reza Youssefi Kamangar; Haleh Akhavan-Niaki
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-31       Impact factor: 0.900

4.  Dobzhansky-Muller incompatibilities in protein evolution.

Authors:  Alexey S Kondrashov; Shamil Sunyaev; Fyodor A Kondrashov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

5.  Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.

Authors:  S Gantla; C T Bakker; B Deocharan; N R Thummala; J Zweiner; M Sinaasappel; J Roy Chowdhury; P J Bosma; N Roy Chowdhury
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Hb Bristol-Alesha presenting thalassemia-type hyperunstable hemoglobinopathy.

Authors:  Gen Kano; Akira Morimoto; Shigeyoshi Hibi; Chika Tokuda; Shinjiro Todo; Tohru Sugimoto; Teruo Harano; Ayako Miyazaki; Akira Shimizu; Shinsaku Imashuku
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

Review 7.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

8.  Two missense mutations in the beta-globin gene can cause severe beta thalassemia. Hemoglobin Medicine Lake (beta 32[B14]leucine-->glutamine; 98 [FG5] valine-->methionine).

Authors:  M B Coleman; Z H Lu; C M Smith; J G Adams; A Harrell; M Plonczynski; M H Steinberg
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.

Authors:  Faten Moassas; Mohamad Sayah Nweder; Hossam Murad
Journal:  BMC Pediatr       Date:  2019-02-18       Impact factor: 2.125

10.  Mutations in the conserved loop of human U5 snRNA generate use of novel cryptic 5' splice sites in vivo.

Authors:  J J Cortes; E J Sontheimer; S D Seiwert; J A Steitz
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.